Do analysts prefer BNR or VMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate BNR or AIRS?

AirSculpt Technologies has a consensus target price of $4.50, indicating a potential downside of 15.89%. Given AirSculpt Technologies' stronger consensus rating and higher possible upside, analysts plainly believe AirSculpt Technologies is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AirSculpt Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts rate BNR or AUNA?

Auna has a consensus target price of $6.97, indicating a potential upside of 41.17%. Given Auna's stronger consensus rating and higher possible upside, analysts plainly believe Auna is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Auna 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.40

Which has higher valuation & earnings, BNR or AUNA?

Auna has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Burning Rock Biotech $514.43M 0.18 -$7.92M -$0.82 N/A Auna $4.52B 0.08 $27.39M $0.26 18.98

Do analysts recommend BNR or SBC?

SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 196.17%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SBC Medical Group 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media prefer BNR or SBC?

In the previous week, Burning Rock Biotech had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 4 mentions for Burning Rock Biotech and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.28 beat Burning Rock Biotech's score of 1.22 indicating that SBC Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SBC Medical Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer LFMD or BNR?

LifeMD currently has a consensus target price of $9.14, suggesting a potential upside of 94.53%. Given LifeMD's stronger consensus rating and higher probable upside, analysts plainly believe LifeMD is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Burning Rock Biotech (BNR) Competitors

$8.59 -0.24 (-2.72%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$8.67 +0.08 (+0.93%)

As of 06/12/2026 06:34 PM Eastern

Compare

BNR vs. VMD, AIRS, AUNA, SBC, and LFMD

Should you buy Burning Rock Biotech stock or one of its competitors? MarketBeat compares Burning Rock Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Burning Rock Biotech include Viemed Healthcare (VMD), AirSculpt Technologies (AIRS), Auna (AUNA), SBC Medical Group (SBC), and LifeMD (LFMD). These companies are all part of the "healthcare" industry.

How does Burning Rock Biotech compare to Viemed Healthcare?

Burning Rock Biotech (NASDAQ:BNR) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

In the previous week, Burning Rock Biotech had 3 more articles in the media than Viemed Healthcare. MarketBeat recorded 4 mentions for Burning Rock Biotech and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.89 beat Burning Rock Biotech's score of 1.22 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Burning Rock Biotech	Positive
Viemed Healthcare	Very Positive

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Viemed Healthcare has a net margin of 5.20% compared to Burning Rock Biotech's net margin of -11.57%. Viemed Healthcare's return on equity of 10.52% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
Viemed Healthcare	5.20%	10.52%	7.60%

Viemed Healthcare has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$514.43M	0.18	-$7.92M	-$0.82	N/A
Viemed Healthcare	$270.28M	1.48	$14.93M	$0.37	28.24

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Burning Rock Biotech has a beta of 1.32, meaning that its share price is 32% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.12, meaning that its share price is 12% more volatile than the broader market.

Summary

Viemed Healthcare beats Burning Rock Biotech on 10 of the 14 factors compared between the two stocks.

How does Burning Rock Biotech compare to AirSculpt Technologies?

Burning Rock Biotech (NASDAQ:BNR) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

In the previous week, Burning Rock Biotech had 3 more articles in the media than AirSculpt Technologies. MarketBeat recorded 4 mentions for Burning Rock Biotech and 1 mentions for AirSculpt Technologies. Burning Rock Biotech's average media sentiment score of 1.22 beat AirSculpt Technologies' score of 0.91 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Burning Rock Biotech	Positive
AirSculpt Technologies	Positive

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Comparatively, 44.6% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

AirSculpt Technologies has a net margin of -7.39% compared to Burning Rock Biotech's net margin of -11.57%. AirSculpt Technologies' return on equity of -4.98% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
AirSculpt Technologies	-7.39%	-4.98%	-2.36%

Burning Rock Biotech has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$514.43M	0.18	-$7.92M	-$0.82	N/A
AirSculpt Technologies	$151.82M	2.49	-$11.67M	-$0.17	N/A

AirSculpt Technologies has a consensus target price of $4.50, indicating a potential downside of 15.89%. Given AirSculpt Technologies' stronger consensus rating and higher possible upside, analysts plainly believe AirSculpt Technologies is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Burning Rock Biotech has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market. Comparatively, AirSculpt Technologies has a beta of 2.31, indicating that its stock price is 131% more volatile than the broader market.

Summary

AirSculpt Technologies beats Burning Rock Biotech on 10 of the 15 factors compared between the two stocks.

How does Burning Rock Biotech compare to Auna?

Burning Rock Biotech (NASDAQ:BNR) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

In the previous week, Burning Rock Biotech had 4 more articles in the media than Auna. MarketBeat recorded 4 mentions for Burning Rock Biotech and 0 mentions for Auna. Burning Rock Biotech's average media sentiment score of 1.22 beat Auna's score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Burning Rock Biotech	Positive
Auna	Neutral

Burning Rock Biotech has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market. Comparatively, Auna has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

Auna has a net margin of 1.53% compared to Burning Rock Biotech's net margin of -11.57%. Auna's return on equity of 16.25% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
Auna	1.53%	16.25%	4.03%

Auna has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$514.43M	0.18	-$7.92M	-$0.82	N/A
Auna	$4.52B	0.08	$27.39M	$0.26	18.98

30.0% of Burning Rock Biotech shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Auna has a consensus target price of $6.97, indicating a potential upside of 41.17%. Given Auna's stronger consensus rating and higher possible upside, analysts plainly believe Auna is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Summary

Auna beats Burning Rock Biotech on 11 of the 17 factors compared between the two stocks.

How does Burning Rock Biotech compare to SBC Medical Group?

Burning Rock Biotech (NASDAQ:BNR) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

SBC Medical Group has a net margin of 24.09% compared to Burning Rock Biotech's net margin of -11.57%. SBC Medical Group's return on equity of 15.90% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
SBC Medical Group	24.09%	15.90%	11.61%

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by company insiders. Comparatively, 81.7% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

SBC Medical Group has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$514.43M	0.18	-$7.92M	-$0.82	N/A
SBC Medical Group	$169.34M	1.74	$50.99M	$0.39	7.36

Burning Rock Biotech has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 196.17%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Burning Rock Biotech had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 4 mentions for Burning Rock Biotech and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.28 beat Burning Rock Biotech's score of 1.22 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SBC Medical Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

SBC Medical Group beats Burning Rock Biotech on 13 of the 16 factors compared between the two stocks.

How does Burning Rock Biotech compare to LifeMD?

LifeMD (NASDAQ:LFMD) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

LifeMD has a net margin of 2.37% compared to Burning Rock Biotech's net margin of -11.57%. Burning Rock Biotech's return on equity of -10.98% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	2.37%	-150.88%	-22.59%
Burning Rock Biotech	-11.57%	-10.98%	-7.33%

LifeMD has a beta of 1.98, indicating that its stock price is 98% more volatile than the broader market. Comparatively, Burning Rock Biotech has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market.

35.5% of LifeMD shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 18.4% of LifeMD shares are owned by insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Burning Rock Biotech had 3 more articles in the media than LifeMD. MarketBeat recorded 4 mentions for Burning Rock Biotech and 1 mentions for LifeMD. Burning Rock Biotech's average media sentiment score of 1.22 beat LifeMD's score of 0.58 indicating that Burning Rock Biotech is being referred to more favorably in the news media.

Company	Overall Sentiment
LifeMD	Positive
Burning Rock Biotech	Positive

LifeMD currently has a consensus target price of $9.14, suggesting a potential upside of 94.53%. Given LifeMD's stronger consensus rating and higher probable upside, analysts plainly believe LifeMD is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

LifeMD has higher earnings, but lower revenue than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	1.17	$14.35M	$0.05	94.00
Burning Rock Biotech	$514.43M	0.18	-$7.92M	-$0.82	N/A

Summary

LifeMD beats Burning Rock Biotech on 10 of the 16 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BNR vs. The Competition

Export

Metric	Burning Rock Biotech	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$90.35M	$4.17B	$6.72B	$12.07B
Dividend Yield	N/A	2.11%	3.09%	5.66%
P/E Ratio	-10.48	42.07	28.46	24.42
Price / Sales	0.18	46.64	402.69	88.50
Price / Cash	N/A	39.77	23.76	55.64
Price / Book	1.18	4.72	5.78	6.80
Net Income	-$7.92M	$31.68M	$205.40M	$338.00M
7 Day Performance	-6.73%	-0.65%	-0.07%	2.68%
1 Month Performance	-53.72%	-3.72%	0.43%	1.56%
1 Year Performance	124.28%	27.02%	36.78%	30.59%

Burning Rock Biotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BNR Burning Rock Biotech	1.8125 of 5 stars	$8.59 -2.7%	N/A	+124.3%	$90.35M	$514.43M	N/A	1,390	News Coverage Positive News Earnings Report Analyst Downgrade Gap Up High Trading Volume
VMD Viemed Healthcare	2.4594 of 5 stars	$9.92 flat	N/A	+57.1%	$380.30M	$270.28M	26.81	1,382	Positive News
AIRS AirSculpt Technologies	1.4415 of 5 stars	$5.28 +5.0%	$4.50 -14.8%	+17.6%	$354.85M	$151.82M	N/A	240	Analyst Forecast
AUNA Auna	4.7995 of 5 stars	$4.80 +6.1%	$6.97 +45.3%	-21.9%	$334.54M	$1.23B	18.44	15,254	Positive News Gap Up
SBC SBC Medical Group	3.7715 of 5 stars	$2.99 +1.0%	$8.50 +184.3%	-35.2%	$303.63M	$173.61M	7.67	N/A	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BNR) was last updated on 6/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Burning Rock Biotech (BNR) Competitors

BNR vs. VMD, AIRS, AUNA, SBC, and LFMD

How does Burning Rock Biotech compare to Viemed Healthcare?

Summary

How does Burning Rock Biotech compare to AirSculpt Technologies?

Summary

How does Burning Rock Biotech compare to Auna?

Summary

How does Burning Rock Biotech compare to SBC Medical Group?

Summary

How does Burning Rock Biotech compare to LifeMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR vs. The Competition

Burning Rock Biotech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Burning Rock Biotech (BNR) Competitors

BNR vs. VMD, AIRS, AUNA, SBC, and LFMD

How does Burning Rock Biotech compare to Viemed Healthcare?

Does the media prefer BNR or VMD?

Do institutionals and insiders hold more shares of BNR or VMD?

Is BNR or VMD more profitable?

Which has higher valuation & earnings, BNR or VMD?

Do analysts prefer BNR or VMD?

Which has more risk and volatility, BNR or VMD?

Summary

How does Burning Rock Biotech compare to AirSculpt Technologies?

Does the media refer more to BNR or AIRS?

Do insiders and institutionals believe in BNR or AIRS?

Is BNR or AIRS more profitable?

Which has higher valuation & earnings, BNR or AIRS?

Do analysts rate BNR or AIRS?

Which has more risk & volatility, BNR or AIRS?

Summary

How does Burning Rock Biotech compare to Auna?

Does the media refer more to BNR or AUNA?

Which has more risk & volatility, BNR or AUNA?

Is BNR or AUNA more profitable?

Which has higher valuation & earnings, BNR or AUNA?

Do insiders and institutionals believe in BNR or AUNA?

Do analysts rate BNR or AUNA?

Summary

How does Burning Rock Biotech compare to SBC Medical Group?

Is BNR or SBC more profitable?

Do institutionals and insiders have more ownership in BNR or SBC?

Which has better earnings and valuation, BNR or SBC?

Which has more risk & volatility, BNR or SBC?

Do analysts recommend BNR or SBC?

Does the media prefer BNR or SBC?

Summary

How does Burning Rock Biotech compare to LifeMD?

Is LFMD or BNR more profitable?

Which has more risk & volatility, LFMD or BNR?

Do insiders & institutionals hold more shares of LFMD or BNR?

Does the media favor LFMD or BNR?

Do analysts prefer LFMD or BNR?

Which has stronger valuation and earnings, LFMD or BNR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR vs. The Competition

Burning Rock Biotech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools